Atea Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for AVIR.

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for AVIR is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	0
Sell	2	2	2	2	2	1
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eric Joseph JP Morgan	JP Morgan	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Aug 10, 2023
Eric Joseph JP Morgan	JP Morgan	Hold Maintains $12 → $8	Hold	Maintains	$12 → $8	+116.22%	Mar 16, 2023
Roanna Ruiz SVB Leerink	SVB Leerink	Hold Maintains $8 → $6	Hold	Maintains	$8 → $6	+62.16%	Jan 27, 2023
Matthew Harrison Morgan Stanley	Morgan Stanley	Sell Maintains $7 → $4	Sell	Maintains	$7 → $4	+8.11%	Jan 24, 2023
Matthew Harrison Morgan Stanley	Morgan Stanley	Sell Maintains $6 → $7	Sell	Maintains	$6 → $7	+89.19%	Aug 15, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

43.81M

EPS This Year

-2.82

from -1.63

EPS Next Year

-2.98

from -2.82

Year	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	-	48.63M	351.37M	-	-	-	43.81M	138.36M
Revenue Growth	-	-	622.49%	-	-	-	-	215.83%
EPS	-1.39	-0.51	1.37	-1.39	-1.63	-2.82	-2.98	-1.33
EPS Growth	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	50.3M	185.1M
Avg	n/a	43.8M	138.4M
Low	n/a	37.2M	93.1M

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	322.6%
Avg	-	-	215.8%
Low	-	-	112.5%

EPS Forecast

EPS	2024	2025	2026
High	-2.63	-2.63	-0.63
Avg	-2.82	-2.98	-1.33
Low	-2.97	-3.08	-1.96

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.